New birth control implant shows promise in early safety trial
NCT ID NCT05174884
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a new contraceptive implant called Casea S in 20 healthy women. The goal is to check how the body processes the hormone, how easy it is to remove, and if it's safe. The implant aims to prevent pregnancy for at least 78 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONTRACEPTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinica Profamilia
Santo Domingo, DN, 10401, Dominican Republic
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Texts and local mentors: a new way to empower teen girls on contraception?
- Could a single implant replace the morning-after pill?
- New condom materials put to the test: can plastic beat latex?
- New birth control pill aims to cut estrogen while boosting effectiveness
- Village women trained as mentors to help others take charge of birth control decisions
- Your DNA could determine if your birth control works